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Abstract
Endometrial cytokine expression is poorly understood. T-Bet and GATA-3 regulate cytokine
expression in T-lymphocytes. Previous work has demonstrated expression of T-Bet in human
endometrium. Changes in human endometrial T-Bet and GATA-3 mRNA and protein expression
during the normal menstrual cycle were characterized. Human endometrium from each phase of the
menstrual cycle underwent real-time reverse-transcriptase polymerase chain reaction and
immunohistochemistry to examine expression and localization. T-Bet and GATA-3 mRNA were
increased in the late secretory phase. Progesterone receptor (PR) mRNA was increased during the
proliferative and early secretory phases. T-Bet and GATA-3 proteins localized cytoplasmically in
the late secretory phase. PR protein displayed nuclear localization and maximal immunostaining
during the early secretory phase. T-Bet and GATA-3 are expressed in endometrial epithelium
cyclically during the menstrual cycle. T-Bet and GATA-3 are both upregulated during the late
secretory phase and in the same cell types. The expression patterns of T-Bet and GATA-3 oppose
PR, suggesting antagonistic function and/or regulation between PR and T-Bet/GATA-3.
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Epithelial cells throughout the body function as a physical barrier to pathogen invasion. They
also provide a chemical defense by recognizing and initiating immune responses to potential
pathogens. Epithelial immune responses must be tightly regulated to prevent inappropriate
immune responses to commensal or beneficial microbes.A major part of immune response by
epithelia is the production and secretion of cytokines.
Endometrial epithelial cells are a rich source of cytokine production. Endometrial cytokines
regulate local immune response but also act to regulate menstruation and embryo
implantation.The regulation of cytokines in the endometrium is complex. This regulation must
support immunological defense against pathogens, permit immunological tolerance to an
invading semiallogeneic trophoblast, and enable the shedding and apoptosis that occurs during
menstruation. However, the critical mechanisms regulating endometrial cytokine expression
remain poorly understood.
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In T-lymphocytes, 2 transcription factors—T-box expressed in T cell (T-Bet) and GATA-3—
have a profound effect on the overall patterns of cytokine expression. For example, T-Bet is
required for T cells to differentiate into a TH1 cytokine expression pattern (interleukin [IL]–2,
IL-3, interferon γ, and tumor necrosis factor–α).1 In contrast, GATA-3 is required for T cells
to differentiate into a TH2 cytokine expression pattern (IL-4, IL-5, IL-6, IL-10, and IL-13).2
The expression of TH1 and TH2 cytokines is usually mutually exclusive and generally thought
to have opposing immunological function. It has been suggested that polarization of cytokine
expression away from the generally proinflammatory TH1 response and toward the generally
anti-inflammatory TH2 response is essential for pregnancy maintenance and is altered in
recurrent miscarriage.3–12 Although there clearly is a bias toward TH2 cytokine expression
during pregnancy, the relative roles of eliminating TH1 cytokine expression and promoting
TH2 response is debated.3–12 Our recent finding of T-Bet expression in endometrial
epithelium, a rich source of cytokine expression, suggests a possible role for T-Bet and
GATA-3 in the regulation of endometrial cytokine expression and thus in pregnancy tolerance.
13
Cytokines also play direct roles in the promotion of embryo implantation. For example, Stewart
et al14 showed that female mice lacking the expression of the cytokine leukemia inhibitory
factor (LIF) are completely unreceptive to the implantation of embryos. As might be expected
of a factor critical for implantation, endometrial epithelial LIF expression is cyclic and
regulated by reproductive steroid hormones.15 We recently demonstrated reproductive
hormone regulation of T-Bet expression,13 echoing an earlier study showing effects of low-
dose estrogen on T-Bet expression and/or activity in the brain.16 In vitro evidence also supports
estradiol upregulation of GATA-3 and downregulation of T-Bet mRNA.17 We hypothesize
that estrogen and progesterone regulation of T-Bet and GATA-3 would in turn regulate local
cytokine expression, resulting in changes in endometrial function. We also hypothesize that
T-Bet and GATA-3 would be subject to opposing cyclic regulation since expression of each
directly inhibits expression of the other in T lymphocytes.18 Thus, we seek to characterize
endometrial T-Bet and GATA-3 RNA and protein expression in each phase of the normal
menstrual cycle using quantitative reverse-transcriptase polymerase chain reaction (qRT-PCR)
and immunohistochemistry.
MATERIALS AND METHODS
Endometrial Specimen Collection and Preservation
Endometrial specimens were collected from healthy volunteers under a protocol approved by
the Institutional Review Board of the University of North Carolina at Chapel Hill. All women
were between 19 and 34 years of age and were not taking any medications known to affect
reproductive hormone production or action. Endometrial sampling was done using a Pipelle
sampler. Samples were divided into portions and flash frozen in liquid N2 or placed in formalin.
The formalin-fixed samples were embedded in paraffin and sectioned for immuno-
histochemistry and staining with hematoxylin and eosin (H&E). The flash-frozen samples were
used to generate RNA for real-time RT-PCR.
Cycle Day Identification
Two methods were used to determine the secretory phase day of each sample. Prior to biopsy,
urinary luteinizing hormone (LH) surges were monitored by the subjects using home test kits.
Postbiopsy, H&E-stained sample morphologies were blindly analyzed by a pathologist using
microscopy.
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RNA Isolation and Quantification
Endometrial total RNA was isolated from 21 frozen tissue samples using the
RNAqueous-4PCR Kit (Ambion, Foster City, CA) and the manufacturer’s suggested
conditions. RNA was quantitated using RiboGreen (Molecular Probes, Carlsbad,CA) with a
ribosomal RNA standard curve. First-strand cDNA was synthesized from 100 ng of total RNA
using the Roche 1st Strand cDNA Synthesis Kit for RT-PCR.
For T-Bet, each sample of cDNA was diluted 1:25 and plated in triplicate. Detection used the
following primers and probe (Synthegen, Houston, TX): forward primer, 5′-AAGTTTA
ATCAGCACCAGACAGAG-3′; reverse primer, 5′-
GCCACAGTAAATGACAGGAATGG-3′; and probe, 5′-
AACATCCGCCGTCCCTGCTTGGTG-3′. Primers and probes for cyclophilin (PPIA),
progesterone receptor, and GATA-3 were obtained in a predesigned mix for each gene (Gene
Expression Assays; Applied Biosystems,Foster City,CA).The efficiency of each primer–probe
set was run on each analysis day and used serial dilutions of peripheral blood mononuclear cell
cDNA. The total reaction volume for all real-time PCR experiments was 25 µL. All reactions
were performed in 96-well plates on a Stratagene MX3000 device for 40 two-step cycles (95°
C for 20 seconds and then 60°C for 1 minute) and used a commercially prepared master mix
(ABI).
The efficiency of all PCR reactions ranged from 97% to 103%.The average cycle number at
which the TaqMan fluorescence became detectable above the threshold (Ct) was 31.4 (T-Bet),
27.8 (GATA-3), 23.0 (progesterone receptor [PR]), and 19.6 (PPIA). Ct values were converted
to relative expression using the ΔΔCt method, allowing normalization to both the housekeeping
gene cyclophilin (PPIA) and a single sample in the early secretory phase (LH2) for T-Bet,
GATA-3, and the late secretory phase for PR.
Tissue Preparation and Immunolocalization
Paraffin-embedded tissue samples (n = 8) were sectioned and mounted onto slides. Duplicate
samples were subjected to antigen retrieval using boiling (100°C) citrate buffer (pH = 6.0) for
two 5-minutes intervals. Following antigen retrieval, the slides were immersed in 0.3%
H2O2 + methanol for 30 minutes to quench endogenous peroxidase activity. The T-Bet
antibody (4B10-sc21749; Santa Cruz Biotechnology, Santa Cruz, CA), GATA-3 antibody
(MAB260501, clone-291106; R&D Systems, Minneapolis, MN), PR antibody (A/B,VP-
p977;Vector Laboratories, Burlingame, CA), ER (positive control) antibody (NCL-ER-6F11;
Novocastra, Norwell, MA), and IgG isotype (negative control) antibody (MAB002; R&D
Systems) were diluted 1:20, 1:200, 1:50, 1:40, and 1:50, respectively.The sections were
incubated with primary antibodies overnight at 4°C. The secondary antibody, biotinylated goat
antimouse IgG (BA-9200;Vector Laboratories) was diluted 1:100 and incubated for 1 hour at
room temperature. The stain was then developed using an ABC kit (Vector Laboratories). The
slides were rinsed and counterstained with 5% hematoxylin (DAKO, Glostrup, Denmark).
RESULTS
Healthy, regularly menstruating volunteers had an endometrial biopsy timed by daily urinary
LH surge measurements. An aliquot was placed in formalin for later immunohistochemistry,
and the remaining tissue was flash frozen in liquid nitrogen. RNA was extracted from frozen
tissue, and relative expression of T-Bet and GATA-3 mRNA at each phase of the menstrual
cycle was determined using real-time RT-PCR. The analysis of mRNA expression was based
on 3 proliferative samples (cycle days 1–14), 6 early secretory samples (post–LH surge days
1–4), 9 midsecretory samples (post–LH surge days 5–9), and 3 late secretory samples (post–
LH surge days 10–14). The relative expression of PR, which is expected to fall in the mid and
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late secretory phases,19 was used as a control, and PPIA was chosen as a housekeeping control
gene because it varied only minimally in this sample set and in other endometrial sample sets
in our experience (data not shown).
Formalin-fixed sections were stained with H&E, and histological dating was performed using
the criteria of Noyes et al.20 LH surge and histological dating showed the same trends.
However, if the sample was within 1 day of being in a different cycle phase, histological
determination was used to allow reassignment to 1 day later or earlier and thus to the other
cycle phase.
A 25-fold increase in T-Bet (P <.01; Figure 1) and a 6-fold increase in GATA-3 (P <.01; Figure
2) were observed during the late secretory as compared with the early secretory phase. The
same samples demonstrated a 30-fold decrease in PR between the early and late secretory
phases (Figure 3). Thus, a specific upregulation of mRNA for both T-Bet and GATA-3 is seen
(Figure 1–Figure 3).
After identifying the changes in mRNA levels in whole endometrial tissue,we next sought to
identify the cell types expressing T-Bet and GATA-3 protein and whether relative protein
expression was predicted by mRNA levels. Immunohistochemical localization of T-Bet,
GATA-3, and PR was evaluated at each phase of the menstrual cycle. Several samples from
all phases of the menstrual cycle are represented in Figure 4.
In proliferative samples, both T-Bet and GATA-3 proteins were detected and localized
primarily to the cytoplasm of epithelial cells. In contrast, PR was detected in the nuclei of both
the epithelial and stromal cells of proliferative samples. T-Bet was also found in a small number
of strongly staining smaller cells, likely lymphocytes. In samples from the early secretory
phase, GATA-3 and T-Bet staining was faint and not always detectable, but PR staining was
prominent. A few stromal cells were darkly stained for T-Bet. Samples from the midsecretory
phase (the implantation window) showed a somewhat reduced intensity of nuclear PR staining
and increased cytoplasmic staining for T-Bet and GATA-3 in glandular epithelial cells. In the
late secretory phase, PR protein was, as expected, undetectable in the glandular epithelium but
clearly detectable in some stromal cells.19 Late secretory immunostaining for both T-Bet and
GATA-3 protein expression was markedly elevated in the cytoplasm of the glandular
epithelium. Thus, the intensity of immunohistochemical staining for T-Bet, GATA-3, and PR
generally parallels the mRNA changes. Furthermore, the cell types expressing GATA-3 and
T-Bet appear to be primarily endometrial epithelium, with a small number of stromal cells
(lymphocytes) also positive for T-Bet staining, especially in the proliferative and early
secretory phases.
DISCUSSION
Cytokines play key roles in reproductive, immune, and menstrual functions of human
endometrium. This study was designed to measure the endometrial expression of 2
transcription factors, T-Bet and GATA-3, known to be critical regulators of cytokine
expression in lymphocytes. We have demonstrated that T-Bet and GATA-3 mRNA and protein
are cyclically expressed in human endometrium, predominantly in the epithelial cells.
Furthermore, expression of both was shown to be maximal in the late secretory phase, and both
proteins were primarily localized to the cytoplasm of endometrial epithelial cells.
The cyclical changes in T-Bet and GATA-3 expression strongly suggest regulation by
reproductive steroid hormones. T-Bet promoter activity in an endometrial cell line has been
previously shown to be stimulated by treatment with progesterone in vitro, in a time-dependent
oscillation.13 In the same set of experiments, progesterone treatment also stimulated stat5
binding to the T-Bet promoter, possibly via an autocrine feedback loop involving IL-15
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activation of stat5. Since endometrial IL-15 expression is increased in the late secretory phase
by the action of progesterone on endometrial stromal cells,21 a paracrine effect of IL-15 may
underlie the cyclic expression of T-Bet in the endometrial epithelium. Interestingly,
endometrial stromal expression of IL-15 is also induced by co-culture with trophoblast,22
suggesting a mechanism for possible increased endometrial expression of T-Bet during embryo
implantation.
Another potential mechanism of steroid action on T-Bet and GATA-3 expression is via the
nuclear factor κB (NF-κB) pathway. Both T-Bet and GATA-3 expression can be stimulated
by NF-κB.23–25 Furthermore, NF-κB activity can be inhibited by both estrogen and
progesterone. 26–28 Since estrogen and progesterone and specific subtypes of the estrogen
and progesterone receptors are low in the late luteal phase, falling estrogen and progesterone
actions may disinhibit NF-κB, leading to increased T-Bet and GATA-3 expression.
In lymphocytes, T-Bet expression and GATA-3 expression are generally mutually exclusive,
and the functions of these 2 transcription factors are often antagonistic. 1,18 Despite the
antagonism, common factors have been identified that have similar effects on expression of
both T-Bet and GATA-3. For instance, in classical immune cells, transforming growth factor–
β (TGF-β) has been shown to inhibit both the expression of T-Bet29,30 and differentiation of
TH1-type cells31,32 and the expression of GATA-3 and differentiation TH2-type cells.32 Thus,
our finding that both GATA-3 and T-Bet are maximally expressed in endometrial epithelia
during the late secretory phase, while unexpected, may reflect control through signaling
pathways similar to that associated with TGF-β. Interestingly, several TGF-β isoforms are
strong inhibitors of trophoblast outgrowth and proliferation.33,34 Although the reason for this
double-barreled immune response in the late secretory phase involving both T-Bet and
GATA-3 remains unclear, both factors can activate the expression of COX-2, IL-8, monocyte
chemotactic protein, and IL-2, all of which play functional roles in immune cell migration,
inflammation, and tissue breakdown during menstruation.
Another unexpected finding was that both T-Bet and GATA-3 proteins are immunolocalized
to the cytoplasm of the glandular epithelium rather than the nucleus, where both transcription
factors are thought to function. This cytoplasmic localization suggests either an alternative,
non-transcriptional function or a requirement for activation prior to entering the nucleus.
Mariani et al,35 in developing a model of cross-regulation of T-Bet and GATA-3 in T
lymphocytes, proposed 3 possible mechanisms of inhibition: sequestration by a binding
protein, repression of basal transcription, and repression of autoactivation. One recent study
showed that GATA-3 nuclear translocation is dependent on its phosphorylation on serine
residues by p38 MAPK36; however, the factors determining T-Bet nuclear translocation
remain unreported.
T-Bet was also immunolocalized to the nucleus of a small number of stromal cells during the
proliferative and early secretory phase.This expression pattern is in contrast to the cytoplasmic
expression seen in the glandular cells. These cells are likely lymphocytes or uterine natural
killer cells, both of which are known to express T-Bet.37
This article localizes T-Bet and GATA-3 to human endometrial epithelial cells histologically
and supports previously published endometrial data.13 Expression of T-Bet and GATA-3 has
been characterized in other epithelial tissues, including bronchi and bowel, and alterations in
these epithelia-expressed transcription factors have been linked to human disease. GATA-3 is
underexpressed while T-Bet is overexpressed in the gut mucosa of celiac disease patients.38
GATA-3 is upregulated in human bronchial and nasal mucosa in asthmatic subjects compared
with controls.39 However, in each of these cases, the alterations in transcription factor
expression patterns that result in functional impairment are presumed or demonstrated to be
Inman et al. Page 5













limited to resident lymphocytes, not epithelial cells. Lymphocyte expression may, in fact,
represent only part of the pathogenesis.
Because of the prominent role of cytokines in implantation, menstruation, and endometriosis,
it is tempting to speculate that T-Bet and GATA-3 play a role in endometrial function and
dysfunction. However, T-Bet has not been linked to endometrial dysfunction in any article to
date, nor has any mention of T-Bet appeared in the various microarray studies examining the
physiology and patho-physiology of human endometrium.GATA-3 was shown to be
upregulated in eutopic endometrial stromal cells selected by laser capture microdissection from
patients with endometriosis.40 However, GATA-3 microarray data were not confirmed by an
alternative method, and no other microarray data have mentioned GATA-3. Thus, it is likely
that these cycle-regulated proteins have important effects on endometrial function, but their
role remains speculative.
CONCLUSION
Our data demonstrate GATA-3 and T-Bet expression in human endometrium and suggest
hormonal regulation of expression. Furthermore, we demonstrate a somewhat unexpected
coexpression of these antagonistic transcription factors and unconventional tissue and
subcellular localization. Further studies are required to understand the role of these
transcription factors in the physiology and pathophysiology of human endometrium.
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Relative expression of T-Bet mRNA across the menstrual cycle. Relative mRNA expression
was calculated after real-time reverse-transcriptase polymerase chain reaction using the ΔΔCt
method, with cyclophilin as a housekeeping control gene. Data are expressed as the mean ±
standard deviation of samples grouped by menstrual cycle phase. *P <.01 as compared with
all other phases using 1-way analysis of variance with the Tukey post hoc test. Pro indicates
proliferative; ES, early secretory; MS, midsecretory; LS, late secretory.
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Relative expression of GATA-3 mRNA across the menstrual cycle. Data generation,
representation, and analysis are identical to that in Figure 1. Pro indicates proliferative; ES,
early secretory; MS, midsecretory; LS, late secretory.
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Relative expression of progesterone receptor mRNA across the menstrual cycle. Data
representation and analysis are identical to that in Figure 1. Pro indicates proliferative; ES,
early secretory; MS, midsecretory; LS, late secretory.
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Immunohistochemistry. Proliferative (Pro), cycle day 5; early secretory (ES), luteinizing
hormone (LH) day 1; midsecretory (MS), LH day 8; late secretory (LS), LH day 12.
Magnification 20×
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